Shil Apurba, Arava Noa, Levi Noam, Levine Liron, Golan Hava, Meiri Gal, Michaelovski Analya, Tsadaka Yair, Aran Adi, Menashe Idan
Department of Epidemiology, Biostatistics and Community Health Sciences, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Azrieli National Centre for Autism and Neurodevelopment Research, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Sci Rep. 2025 Apr 15;15(1):13024. doi: 10.1038/s41598-025-96063-x.
Discerning clinically relevant autism spectrum disorder (ASD) candidate variants from whole-exome sequencing (WES) data is complex, time-consuming, and labor-intensive. To this end, we developed AutScore, an integrative prioritization algorithm of ASD candidate variants from WES data and assessed its performance to detect clinically relevant variants. We studied WES data from 581 ASD probands, and their parents registered in the Azrieli National Center database for Autism and Neurodevelopment Research. We focused on rare allele frequency (< 1%) and high-quality proband-specific variants affecting genes associated with ASD or other neurodevelopmental disorders (NDDs). We developed AutScore and AutScore.r and assigned each variant based on their pathogenicity, clinical relevance, gene-disease association, and inheritance patterns. Finally, we compared the performance of both AutScore versions with the rating of clinical experts and the NDD variant prioritization algorithm, AutoCaSc. Overall, 1161 rare variants distributed in 687 genes in 441 ASD probands were evaluated by AutScore with scores ranging from - 4 to 25, with a mean ± SD of 5.89 ± 4.18. AutScore.r cut-off of ≥ 0.335 performs better than AutoCaSc and AutScore in detecting clinically relevant ASD variants, with a detection accuracy rate of 85% and an overall diagnostic yield of 10.3%. Five variants with AutScore.r of ≥ 0.335 were distributed in five novel ASD candidate genes. AutScore.r is an effective automated ranking system for ASD candidate variants that could be implemented in ASD clinical genetics pipelines.
从全外显子组测序(WES)数据中识别具有临床相关性的自闭症谱系障碍(ASD)候选变异体是复杂、耗时且劳动密集型的。为此,我们开发了AutScore,这是一种从WES数据中对ASD候选变异体进行综合排序的算法,并评估了其检测临床相关变异体的性能。我们研究了在阿兹列里国家自闭症和神经发育研究中心数据库中注册的581名ASD先证者及其父母的WES数据。我们关注罕见等位基因频率(<1%)以及影响与ASD或其他神经发育障碍(NDD)相关基因的高质量先证者特异性变异体。我们开发了AutScore和AutScore.r,并根据其致病性、临床相关性、基因-疾病关联和遗传模式为每个变异体赋值。最后,我们将两个版本的AutScore的性能与临床专家的评级以及NDD变异体排序算法AutoCaSc进行了比较。总体而言,AutScore对441名ASD先证者中687个基因的1161个罕见变异体进行了评估,分数范围为-4至25,平均值±标准差为5.89±4.18。AutScore.r≥0.335的截断值在检测临床相关ASD变异体方面比AutoCaSc和AutScore表现更好,检测准确率为85%,总体诊断率为10.3%。五个AutScore.r≥0.335的变异体分布在五个新的ASD候选基因中。AutScore.r是一种有效的ASD候选变异体自动排序系统,可应用于ASD临床遗传学流程。